A high-throughput pipeline for identifying nanobodies that target and neutralize SARS-CoV-2

By | October 27, 2021
Researchers in the United States have developed a cost-effective, high-throughput pipeline for identifying effective nanobodies that target and neutralize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).